European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

Department of Health and Human Services STTR Phase I

Department of Health and Human Services STTR Phase I (United States): 192 grants in the last 24 months to 182 recipients; a typical grant is about €280,000. It funds most often: Feasibility studies and proof of concept. Data as of 17 November 2026; updated daily.

Grants in the last 24 months
192
Recipients
182
Total, last 24 months
≈ €59,000,000
Typical grant (median)
≈ €280,000
Open calls
0
Calls on the site
0

Open calls

No records yet.

Latest grants

Most grants went to

  1. Aleutian Therapeutics, Inc. 3
  2. L2 Diagnostics LLC 3
  3. IMMUNOGENIK, Inc. 2
  4. Via Therapeutics, LLC 2
  5. Gateway Bio, Inc. 2
  6. Bedrock Therapeutics, Inc. 2
  7. Lactiga Us Inc. 2
  8. Northstar Genomics, LLC 2
  9. Safi Biotherapeutics Inc 1
  10. Neurolux, Inc. 1

What the money buys

Who it is for

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does Department of Health and Human Services STTR Phase I open calls?
No call is open right now.
How much is a grant from Department of Health and Human Services STTR Phase I?
In the last 24 months the median grant was about €280,000; 192 grants, about €59,000,000 in all.
Who gets grants from Department of Health and Human Services STTR Phase I?
Most grants in the last 24 months: ALEUTIAN THERAPEUTICS, INC. (3), L2 DIAGNOSTICS LLC (3) and IMMUNOGENIK, INC. (2).
What does Department of Health and Human Services STTR Phase I fund?
Most often: Feasibility studies and proof of concept.